- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
UPDATED Jun 27, 2022
Potentially undervalued companies with a strong past performance and robust balance sheet.
60 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NOVO BNovo Nordisk | kr.795.00 | 4.4% | 53.2% | kr.1.8t | kr.805.12 | PS36.6x | E14.3% | 1.3% | ||
| 603392Beijing Wantai Biological Pharmacy Enterprise | CNÂ¥150.15 | 3.0% | -15.4% | CNÂ¥132.8b | CNÂ¥204.78 | PS43.1x | E26.7% | 0.09% | ||
| HZNPHorizon Therapeutics | US$85.49 | 3.6% | -10.8% | US$19.7b | US$138.64 | PS22.8x | E24.3% | n/a | ||
| INCYIncyte | US$77.36 | 8.5% | -9.6% | US$17.1b | US$92.31 | PS18.4x | E27.7% | n/a | ||
| 300347Hangzhou Tigermed Consulting | CNÂ¥110.09 | 9.9% | -43.4% | CNÂ¥89.7b | CNÂ¥147.13 | PS32.4x | E18.9% | 0.5% | ||
| 661Changchun High & New Technology Industry (Group) | CNÂ¥226.69 | 5.4% | -41.2% | CNÂ¥88.1b | CNÂ¥292.43 | PS22.8x | E22.7% | 0.4% | ||
| 300601Shenzhen Kangtai Biological Products | CNÂ¥43.16 | 1.3% | -52.7% | CNÂ¥48.9b | CNÂ¥57.75 | PS32x | E27.6% | 1.7% | ||
| EXELExelixis | US$22.22 | 19.7% | 23.3% | US$7.1b | US$26.56 | PS23.9x | E27.0% | n/a | ||
| A302440SK bioscienceLtd | â‚©108,000.00 | 7.5% | -31.6% | â‚©8.4t | â‚©167,222.22 | PS24.3x | E14.0% | n/a | ||
| HALOHalozyme Therapeutics | US$47.04 | 6.6% | 2.4% | US$6.5b | US$55.00 | PS14.9x | E17.8% | n/a | ||
| 603707Nanjing King-Friend Biochemical Pharmaceutical | CNÂ¥28.74 | -3.6% | -9.4% | CNÂ¥35.4b | CNÂ¥31.67 | PS31.9x | E26.6% | 0.5% | ||
| MEDPMedpace Holdings | US$153.69 | 13.5% | -15.3% | US$4.9b | US$133.00 | PS24.7x | E13.4% | n/a | ||
| APNAspen Pharmacare Holdings | R142.26 | 4.4% | -9.3% | R63.5b | R247.75 | PS10.8x | E20.4% | 1.8% | ||
| 4516Nippon Shinyaku | JPÂ¥8,210.00 | 9.5% | -9.6% | JPÂ¥538.8b | JPÂ¥10,280.00 | PS24x | E17.5% | 1.4% | ||
| 867China Medical System Holdings | HK$12.50 | 4.9% | -40.2% | HK$30.8b | HK$16.89 | PS8.7x | E8.0% | 4.6% | ||
| 423Dong-E-E-JiaoLtd | CNÂ¥36.61 | -1.6% | 6.0% | CNÂ¥23.8b | CNÂ¥40.68 | PS47.8x | E29.5% | 1.8% | ||
| ROVILaboratorios Farmaceuticos Rovi | €61.00 | 6.9% | 8.2% | €3.3b | €76.27 | PS18.4x | E10.7% | 1.6% | ||
| RICHTERRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt | Ft6,960.00 | 0.6% | -13.3% | Ft1.3t | Ft8,676.86 | PS8.6x | E19.0% | 3.2% | ||
| SFZNSiegfried Holding | CHF636.50 | 8.8% | -26.6% | CHF2.7b | CHF861.56 | PS28.3x | E12.1% | 0.5% | ||
| INDVIndivior | UK£3.17 | 12.4% | 118.9% | UK£2.2b | UK£3.76 | PS16.4x | E11.6% | 0% | ||
| CORTCorcept Therapeutics | US$25.10 | 21.3% | 9.6% | US$2.7b | US$26.83 | PS23.8x | E20.8% | n/a | ||
| 300841Chengdu Kanghua Biological Products | CNÂ¥109.81 | 16.8% | -38.5% | CNÂ¥14.4b | CNÂ¥158.78 | PS17.1x | E27.8% | 0.9% | ||
| GTIIGreen Thumb Industries | CA$11.37 | -5.3% | -71.9% | CA$2.7b | CA$42.30 | PS22.2x | E37.8% | n/a | ||
| SQURPHARMASquare Pharmaceuticals | ৳215.80 | 0.2% | 0.9% | ৳191.3b | ৳320.40 | PS10.3x | E11.6% | 2.8% |